Table 2. Prevalence of Prothrombotic and... | American Society of Hematology

Table 2.

Prevalence of Prothrombotic and Apo E4 Polymorphisms Among Patients With AMI and Controls

Polymorphism	AMI Patients (%)	Controls (%)	OR	95% CI
F V G1691A^*	6.3	6.4	0.97	0.33-2.76
MTHFR 677T^†	24.1	10.7	2.65	1.35-5.25
Apo E4 allele frequency	9.4	5.3	1.88	0.90-3.91
F II G20210A^*	5.9	3.4	1.78	0.46-6.94

Polymorphism	AMI Patients (%)	Controls (%)	OR	95% CI
F V G1691A^*	6.3	6.4	0.97	0.33-2.76
MTHFR 677T^†	24.1	10.7	2.65	1.35-5.25
Apo E4 allele frequency	9.4	5.3	1.88	0.90-3.91
F II G20210A^*	5.9	3.4	1.78	0.46-6.94

Heterozygotes.

Homozygotes.